www.formation.bioHealthcare / BioTech & PharmaFounded: 2013Funding to Date: $615.78MM
Formation Bio is a pharmaceutical company that uses AI aiming to streamline and accelerate the development of drug treatments. Formation Bio was founded in 2016 and is headquartered in New York, NY. The company strives to address key limitations in the traditional drug development process by seeking to expedite drug development rather than focusing on the discovery of new treatments. Formation Bio partners with biotech and pharmaceutical companies to acquire and co-develop clinical-stage drug candidates, with the goal of reaching patients faster.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
06/26/2024 | Series D | $372MM | $xx.xx | $1.48B | Andreessen Horowitz, Sanofi, Sequoia Capital, Thrive Capital, Emerson Collective, Lachy Groom, SV Angel Growth, FPV Ventures | |
Price per Share
$xx.xx
Shares Outstanding
45,463,211
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Andreessen Horowitz, Sanofi, Sequoia Capital, Thrive Capital, Emerson Collective, Lachy Groom, SV Angel Growth, FPV Ventures
|
||||||
01/06/2021 | Series C | $156.42MM | $xx.xx | $1.04B | Sam Altman, Lachy Groom, Sequoia Capital, Thrive Capital, Casdin Capital, Dragoneer, Section 32, John Doerr, Spark Capital, Felicis Ventures, Sound Ventures, Arrowmark | |
Price per Share
$xx.xx
Shares Outstanding
24,047,068
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Sam Altman, Lachy Groom, Sequoia Capital, Thrive Capital, Casdin Capital, Dragoneer, Section 32, John Doerr, Spark Capital, Felicis Ventures, Sound Ventures, Arrowmark
|
||||||
10/15/2018 | Series B | $70MM | $xx.xx | $377.41MM | Thrive Capital, Sequoia Capital, Sound Ventures, TQ Ventures, Felicis Ventures | |
Price per Share
$xx.xx
Shares Outstanding
15,025,630
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Thrive Capital, Sequoia Capital, Sound Ventures, TQ Ventures, Felicis Ventures
|
||||||
09/28/2017 | Series A | $15.11MM | $xx.xx | $65.83MM | Thrive Capital, Sequoia Capital | |
Price per Share
$xx.xx
Shares Outstanding
26,243,120
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Thrive Capital, Sequoia Capital
|
||||||
06/30/2016 | Series Seed | $2.25MM | $xx.xx | $9MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
19,490,650
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|